we need to be careful reading between the lines, until we have Kenactiv's data.
as CSJ noted, accountants always include the doom&gloom clauses, just in case.
the joy of modern litigious liability issues.
and your last read between the lines promised us:
-- imminent $2.50 share price.
-- short squeeze.
-- etc...
reality is we know nothing tangible about Kenactiv yet.
if unsavvy traders read this 10K without realizing it only reflects OPHI (one division of the new entity), they'll see a $1.4m net loss on $874k sales, and our current $40m-60m market cap will seem silly, and we'll see a nasty tumbled back down to cents.
hopefully Kenactiv's data is more compelling and profitable, and some deep pocket buyers know that, and prop up the price.
time will tell, as it always does...
in theory, in 3 months when we get the Q1 2013 10Q, including some Kenactiv data.
99.99% of all pinks are scams. Best to assume the other 0.01% are as well.
